Hi-CRATES CO.,LTD. (4172.T)
Okayama, JP
Hi-CRATES CO.,LTD. specializes in the creation, sale, and maintenance of comprehensive electronic medical record systems tailored for dental practices. Beyond its core EMR offerings, the company also develops and supports applications for iPads and web platforms. Its extensive product portfolio features advanced solutions such as AI and voice-activated EMRs, tools for visual and periodontal examinations, medical interview software, self-pay estimation systems, and image management. Other notable products include systems for displaying customer information during calls, managing sub-clinical records, generating treatment proposals and quotes, facilitating oral X-ray examinations, cloud-based reservation management, online consultation services, digital patient registration, and automated payment and change dispensing machines. Established in 1978, the company is headquartered in Okayama, Japan. It was previously known as TOWA Hi SYSTEM CO.,LTD., undergoing a name change to Hi-CRATES CO.,LTD. in January 2026.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -3.20% | -6.45% | -7.72% | -5.89% | -5.54% | +0.95% | +33.35% | -25.40% | -48.02% | -48.02% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-09 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+13.9% ★ Q1'26: +3.4% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+11.5% Q1'26: +1.9% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+21.4% ★ Q1'26: +65.0% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+27.1% ★ Q1'26: +29.6% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+21.4% ★ Q1'26: +19.3% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: 0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Sep 2021 actual |
Sep 2022 actual |
Sep 2023 actual |
Sep 2024 actual |
Sep 2025 actual |
Sep 2026 1 Rev. Ana. 1 EPS Ana. |
Sep 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|
| Revenue |
2.37B
est: 2.15B (+10.2%)
|
2.22B
est: 2.31B (-4.1%)
|
2.04B
est: 2.33B (-12.5%)
|
2.11B
est: 2.29B (-7.7%)
|
2.41B
est: 2.35B (+2.4%)
|
2.50B
2.50B – 2.50B
+6.4% YoY
|
2.65B
2.65B – 2.65B
+6.0% YoY
|
| EBITDA |
575.05M
est: 503.62M (+14.2%)
|
527.25M
est: 541.34M (-2.6%)
|
299.00M
est: 546.49M (-45.3%)
|
500.83M
est: 536.65M (-6.7%)
|
739.43M
est: 550.47M (+34.3%)
|
585.61M
585.61M – 585.61M
+6.4% YoY
|
620.75M
620.75M – 620.75M
+6.0% YoY
|
| EBIT |
539.55M
est: 441.48M (+22.2%)
|
478.25M
est: 474.54M (+0.8%)
|
230.93M
est: 479.06M (-51.8%)
|
422.23M
est: 470.43M (-10.2%)
|
651.03M
est: 482.55M (+34.9%)
|
513.35M
513.35M – 513.35M
+6.4% YoY
|
544.15M
544.15M – 544.15M
+6.0% YoY
|
| Net Income |
375.57M
est: 282.50M (+32.9%)
|
316.28M
est: 319.03M (-0.9%)
|
258.51M
est: 348.00M (-25.7%)
|
401.81M
est: 360.92M (+11.3%)
|
448.09M
est: 450.03M (-0.4%)
|
429.98M
429.98M – 429.98M
-4.5% YoY
|
470.08M
470.08M – 470.08M
+9.3% YoY
|
| SGA |
1.15B
est: 1.15B (-0.3%)
|
1.17B
est: 1.24B (-5.4%)
|
1.20B
est: 1.25B (-4.5%)
|
1.15B
est: 1.23B (-6.9%)
|
1.30B
est: 1.26B (+3.3%)
|
1.34B
1.34B – 1.34B
+6.4% YoY
|
1.42B
1.42B – 1.42B
+6.0% YoY
|
| EPS |
173.64
est: 126.80 (+36.9%)
|
141.95
est: 143.20 (-0.9%)
|
116.03
est: 156.20 (-25.7%)
|
180.35
est: 162.00 (+11.3%)
|
201.13
est: 202.00 (-0.4%)
|
193.00
193.00 – 193.00
-4.5% YoY
|
211.00
211.00 – 211.00
+9.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-26 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-25 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-19 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-18 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-15 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-08 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-07 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-01 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-30 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-04-16 | A- | 4/5 | 4/5 | 3/5 | 5/5 | 1/5 | 3/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Masaya Iizuka | President, Chief Executive Officer & Director | — | male |
| Takeo Nishiyama | Head of Accounting & Finance, Executive Officer & Director | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4172.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
